Substance-Related Disorders
"Substance-Related Disorders" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Disorders related to substance abuse, the side effects of a medication, or toxin exposure.
Descriptor ID |
D019966
|
MeSH Number(s) |
C25 F03.900
|
Concept/Terms |
Drug Dependence- Drug Dependence
- Dependence, Drug
- Drug Addiction
- Addiction, Drug
Substance Abuse- Substance Abuse
- Abuse, Substance
- Abuses, Substance
- Substance Abuses
Substance Dependence- Substance Dependence
- Dependence, Substance
- Substance Addiction
- Addiction, Substance
|
Below are MeSH descriptors whose meaning is more general than "Substance-Related Disorders".
Below are MeSH descriptors whose meaning is more specific than "Substance-Related Disorders".
This graph shows the total number of publications written about "Substance-Related Disorders" by people in UAMS Profiles by year, and whether "Substance-Related Disorders" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2024 | 8 | 7 | 15 | 2023 | 15 | 1 | 16 | 2022 | 25 | 0 | 25 | 2021 | 10 | 0 | 10 | 2020 | 10 | 4 | 14 | 2019 | 18 | 3 | 21 | 2018 | 12 | 6 | 18 | 2017 | 22 | 2 | 24 | 2016 | 17 | 6 | 23 | 2015 | 18 | 10 | 28 | 2014 | 22 | 3 | 25 | 2013 | 18 | 5 | 23 | 2012 | 12 | 7 | 19 | 2011 | 20 | 4 | 24 | 2010 | 10 | 6 | 16 | 2009 | 7 | 3 | 10 | 2008 | 6 | 4 | 10 | 2007 | 12 | 4 | 16 | 2006 | 9 | 4 | 13 | 2005 | 7 | 2 | 9 | 2004 | 8 | 6 | 14 | 2003 | 6 | 0 | 6 | 2002 | 2 | 1 | 3 | 2001 | 4 | 0 | 4 | 2000 | 2 | 1 | 3 | 1999 | 4 | 1 | 5 | 1997 | 12 | 1 | 13 | 1996 | 5 | 2 | 7 | 1995 | 6 | 1 | 7 | 1994 | 8 | 1 | 9 | 1993 | 8 | 1 | 9 | 1992 | 1 | 0 | 1 | 1991 | 3 | 0 | 3 | 1989 | 2 | 1 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Substance-Related Disorders" by people in Profiles over the past ten years.
-
Gurley BJ, Koturbash I. Phenibut: A drug with one too many "buts". Basic Clin Pharmacol Toxicol. 2024 Oct; 135(4):409-416.
-
Pro G, Hayes C, Mancino M. Worsening trends in the frequency of methamphetamine and other stimulant use between treatment admission and discharge. Drug Alcohol Depend. 2024 Sep 01; 262:111403.
-
Shaw HE, Patel DR, Gannon BM, Fitzgerald LR, Carbonaro TM, Johnson CR, Fantegrossi WE. Phencyclidine-Like Abuse Liability and Psychosis-Like Neurocognitive Effects of Novel Arylcyclohexylamine Drugs of Abuse in Rodents. J Pharmacol Exp Ther. 2024 Jun 21; 390(1):14-28.
-
Zielinski MJ, Jahangir T, Praseuth A, Wilson S, McLaughlan CL. Mental Health, Drug Use, and Programming: Applying a Needs Assessment Framework in Arkansas' Largest Jail. J Correct Health Care. 2024 Jun; 30(3):206-215.
-
Leri J, Cisler JM, Dodd CG, Clark SL, Taylor L, Theodorou A, Belford A, Liberzon I, Rathouz PJ, Newport DJ, Devargas C, Wagner K, Nemeroff CB. The role of recurrent trauma on post-traumatic stress disorder symptoms and substance use among trauma exposed youth. Psychiatry Res. 2024 Aug; 338:115980.
-
Zhao S, Mathis W. Understanding Barriers and Facilitators of Primary Care Use Among Assertive Community Treatment Teams Via Qualitative Analysis of Clients and Clinicians. Community Ment Health J. 2024 Oct; 60(7):1271-1282.
-
Tamargo JA, Martin HR, Diaz-Martinez J, Delgado-Enciso I, Johnson A, Bastida Rodriguez JA, Trepka MJ, Brown DR, Garba NA, Roldan EO, Hernandez Suarez Y, Marty AM, Bursac Z, Campa A, Baum MK. Drug use and COVID-19 testing, vaccination, and infection among underserved, minority communities in Miami, Florida. PLoS One. 2024; 19(4):e0297327.
-
Subica AM, Soakai L, Tukumoeatu A, Johnson T, Aitaoto N. Trauma and mental health in Pacific Islanders. Int J Soc Psychiatry. 2024 Aug; 70(5):861-873.
-
Skajaa N, Farkas DK, Laugesen K, Fuglsang CH, Henderson VW, Plana-Ripoll O, Gaist D, S?rensen HT. Mental Health Conditions in Partners and Adult Children of Stroke Survivors. JAMA Netw Open. 2024 Mar 04; 7(3):e243286.
-
Lazic A, Tilford JM, Davis VP, Brown CC. Association of copayments with healthcare utilization and expenditures among Medicaid enrollees with a substance use disorder. J Subst Use Addict Treat. 2024 Jun; 161:209314.
-
Azasu EK, Quarshie EN, Messias E, Larnyoh M, Ali E, Joe S. Psychological and socio-ecological correlates of 12-month suicide behavior among junior high school students in the greater Accra region of Ghana. Soc Psychiatry Psychiatr Epidemiol. 2024 Sep; 59(9):1553-1562.
-
Pro G, Horton H, Tody B, Gu M, Washington T, Williams A, Gorvine MM, Johnson O, Lovelady N, Jackson T, Ray A, Montgomery B, Zaller N. National and state-level trends in the availability of mental health treatment services tailored to individuals ordered to treatment by a court: United States, 2016, 2018, and 2020. Soc Psychiatry Psychiatr Epidemiol. 2024 Oct; 59(10):1815-1824.
-
Steely Smith MK, Hinton-Froese KE, Scarbrough Kamath B, Virmani M, Walters A, Zielinski MJ. Characteristics and Outcomes of Women and Infants Who Received Prenatal Care While Incarcerated in Arkansas State Prison System, 2014-2019. Matern Child Health J. 2024 May; 28(5):935-948.
-
Hai AH, Lopez-Quintero C, Elton A, Curran L, Bo A. The independent and joint effect of socioeconomic status and Multiracial status on the prevalence and frequency of substance use and depression among U.S. adolescents. Addict Behav. 2024 04; 151:107953.
-
Nichols M, Kesaria A, Spencer HJ, Williams HR, Samanta S, Lewis GD. Opioid Use in Patients With Cervical Cancer at a Tertiary Academic Medical Center. Anticancer Res. 2024 Jan; 44(1):151-155.
-
Baloh J, Charton H, Curran GM. Substance Use Disorder Treatment Programs during a Health Crisis: Response to the COVID-19 Pandemic and Future Implications. Subst Use Misuse. 2023; 58(14):1855-1865.
-
Hurlocker MC, Moyers TB, Hatch M, Curran G, McCrady B, Venner KL, Witkiewitz K. Effectiveness and feasibility of a motivational interviewing intake (MII) intervention for increasing client engagement in outpatient addiction treatment: an effectiveness-implementation hybrid design protocol. Addict Sci Clin Pract. 2023 10 21; 18(1):63.
-
al'Absi M, DeAngelis B, Borodovsky J, Sofis MJ, Fiecas M, Budney A. Early life adversity and substance use: The mediating role of mood and the moderating role of impulsivity. J Psychiatr Res. 2023 12; 168:38-44.
-
Struble CA, Borodovsky JT, Habib MI, Livne O, Walsh CA, Aharonovich E, Hasin DS, Budney AJ. Evaluating age-related disparities in cannabis-related problems among LGBT+?versus non-LGBT+?adults. Addict Behav. 2024 01; 148:107861.
-
Sahker E, Pro G, Poudyal H, Furukawa TA. Evaluating the substance use disorder treatment gap in the United States, 2016-2019: A population health observational study. Am J Addict. 2024 01; 33(1):36-47.
-
Gannon BM, Fitzgerald LR, Godwin CO, Hughes-Meredith HD, Rice KC, Fantegrossi WE. Effects of ambient temperature on locomotor activity and place conditioning elicited by abused psychostimulants in mice: Role of 3,4-methylenedioxy moiety. Drug Alcohol Depend. 2023 09 01; 250:110917.
-
Schacht RL, Wenzel KR, Meyer LE, Mette M, Mallik-Kane K, Rabalais A, Berg SK, Fishman M. A pilot test of Written Exposure Therapy for PTSD in residential substance use treatment. Am J Addict. 2023 09; 32(5):488-496.
-
White WR, Ray-Griffith SL, Coker JL. Time to pay attention: an underrecognized casualty of the opioid epidemic. Arch Womens Ment Health. 2023 08; 26(4):561-563.
-
Fujiwara R, Journey M, Al-Doori F, Bell P, Judge B, Miracle K, Ito K, Jones S. Potential neonatal toxicity of new psychoactive substances. Pharmacol Ther. 2023 08; 248:108468.
-
Jones DM, Masyn KE, Spears CA. Associations among discrimination, psychological functioning, and substance use among US Black adults aged 18-28: Moderation by racial attribution and sex. J Subst Use Addict Treat. 2023 10; 153:209080.
-
Timko C, Cucciare MA, Lor MC, Stein M, Vest N. Patient-Concerned Other Dyads' 12-Step Involvement and Patients' Substance Use: A Latent Class Growth Model Analysis. J Stud Alcohol Drugs. 2023 09; 84(5):762-771.
-
Shmulewitz D, Budney AJ, Borodovsky JT, Bujno JM, Walsh CA, Struble CA, Livne O, Habib MI, Aharonovich E, Hasin DS. Dimensionality and differential functioning of DSM-5 cannabis use disorder criteria in an online sample of adults with frequent cannabis use. J Psychiatr Res. 2023 07; 163:211-221.
-
Beckham JC, Calhoun PS, Chen Z, Dennis MF, Kirby AC, Treis ET, Hertzberg JS, Hair LP, Mann AJ, Budney AJ, Kimbrel NA. Development of Mobile Contingency Management for Cannabis Use Reduction. Behav Ther. 2024 Jan; 55(1):1-13.
-
Davis AG, Davis B, Williams Z, Viverito K, Schwartz S, Ramos K, Moreno J, Jackson S, Smith PA, Gay J, Aysta S, Shiber NA. Antiracism and mental health recovery: Bridging the gap to improve health disparities among veteran populations. Psychiatr Rehabil J. 2023 Mar; 46(1):53-54.
-
Gleason N, Smith G, Canning JR, George WH, Larimer ME, Jennings TL, Coleman E, Miner MH. The Relationship Between Alcohol and Drug Use, Compulsive Sexual Behavior, and Condomless Anal Sex in Men Who have Sex with Men: Analysis of Retrospectively-Reported Sexual Behavior. AIDS Behav. 2023 Jul; 27(7):2317-2327.
-
Compton WM, Flannagan KSJ, Silveira ML, Creamer MR, Kimmel HL, Kanel M, Blanco C, Volkow ND. Tobacco, Alcohol, Cannabis, and Other Drug Use in the US Before and During the Early Phase of the COVID-19 Pandemic. JAMA Netw Open. 2023 01 03; 6(1):e2254566.
-
Steely Smith MK, Wilson SH, Zielinski MJ. An integrative literature review of substance use treatment service need and provision to pregnant and postpartum populations in carceral settings. Womens Health (Lond). 2023 Jan-Dec; 19:17455057221147802.
-
Barbotin B, Hoertel N, Olfson M, Blanco C, Sanchez-Rico M, Lejoyeux M, Limosin F, Geoffroy PA. Sleep Complaints Among Adults With Major Depressive Episode Are Associated With Increased Risk of Incident Psychiatric Disorders: Results From a Population-Based 3-Year Prospective Study. J Clin Psychiatry. 2022 12 21; 84(1).
-
Gbadamosi SO, Trepka MJ, Dawit R, Bursac Z, Raymond A, Ladner RA, Sheehan DM. Person-time spent with HIV viral load above 1500 copies/mL among Miami-Dade County Ryan White Program clients, 2017-2019: a retrospective analysis. Ann Epidemiol. 2023 Feb; 78:19-27.
-
Zaller ND, Gorvine MM, Ross J, Mitchell SG, Taxman FS, Farabee D. Providing substance use disorder treatment in correctional settings: knowledge gaps and proposed research priorities-overview and commentary. Addict Sci Clin Pract. 2022 Dec 08; 17(1):69.
-
Timko C, Lor MC, Rossi F, Peake A, Cucciare MA. Caregivers of people with substance use or mental health disorders in the US. Subst Abus. 2022 12; 43(1):1268-1276.
-
Xiong X, Braun S, Stitzer M, Luderer H, Shafai G, Hare B, Stevenson M, Maricich Y. Evaluation of real-world outcomes associated with use of a prescription digital therapeutic to treat substance use disorders. Am J Addict. 2023 01; 32(1):24-31.
-
Desai R, Jain A, Sultan W, Gandhi Z, Raju AR, Varughese VJ, Jnaneswaran G, Agarwal C, Rizvi B, Mansuri Z, Gupta P, Kumar G, Sachdeva R. Hypertensive Crisis-Related Hospitalizations and Subsequent Major Adverse Cardiac Events in Young Adults with Cannabis Use Disorder: A Nationwide Analysis. Medicina (Kaunas). 2022 Oct 16; 58(10).
-
Timko C, Vest N, Cucciare MA, Smelson D, Blonigen D. Substance use and criminogenic thinking: Longitudinal latent class analysis of veterans with criminal histories. J Subst Abuse Treat. 2022 12; 143:108893.
-
Allison MK, Henderson HM, Curran GM, Zielinski MJ. Emergency Department Nurses' Perceptions of Patient Substance Use, Impact on Sexual Assault Care, and Access to Follow-up Behavioral Health Resources. J Emerg Nurs. 2022 Nov; 48(6):698-708.
-
Rezaeiahari M, Fairman BJ. Impact of COVID-19 on the characteristics of opioid overdose deaths in Arkansas. Int J Drug Policy. 2022 11; 109:103836.
-
Subica AM, Guerrero EG, Martin TKK, Okamoto SK, Aitaoto N, Moss HB, Morey BN, Wu LT. Native Hawaiian/Pacific Islander alcohol, tobacco and other drug use, mental health and treatment need in the United States during COVID-19. Drug Alcohol Rev. 2022 11; 41(7):1653-1663.
-
Tobacyk J, Parks BJ, Lovelady N, Brents LK. Qualitative content analysis of public responses to an FDA inquiry on the impact of scheduling changes to kratom. Int J Drug Policy. 2022 10; 108:103817.
-
Wilson CD, Zheng F, Fantegrossi WE. Convulsant doses of abused synthetic cannabinoid receptor agonists AB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA and JWH-018 do not elicit electroencephalographic (EEG) seizures in male mice. Psychopharmacology (Berl). 2022 Oct; 239(10):3237-3248.
-
Sweeney MM, Holtyn AF, Stitzer ML, Gastfriend DR. Practical Technology for Expanding and Improving Substance Use Disorder Treatment: Telehealth, Remote Monitoring, and Digital Health Interventions. Psychiatr Clin North Am. 2022 09; 45(3):515-528.
-
Osibogun O, Erinoso O, Gautam P, Bursac Z, Osibogun A. Marijuana use modifies the association between heavy alcohol consumption and tobacco use patterns among US adults: Findings from Behavioral Risk Factor Surveillance System, 2020. Addict Behav. 2022 12; 135:107435.
-
Cucciare MA, Han X, Timko C. Predictors of alcohol use disorder treatment outcomes over 12 months: Role of concerned others' functioning and Al-Anon participation. Drug Alcohol Depend. 2022 09 01; 238:109546.
-
Han B, Volkow ND, Blanco C, Tipperman D, Einstein EB, Compton WM. Trends in Prevalence of Cigarette Smoking Among US Adults With Major Depression or Substance Use Disorders, 2006-2019. JAMA. 2022 04 26; 327(16):1566-1576.
-
Wilson CD, Hiranita T, Fantegrossi WE. Cannabimimetic effects of abused indazole-carboxamide synthetic cannabinoid receptor agonists AB-PINACA, 5F-AB-PINACA and 5F-ADB-PINACA in mice: Tolerance, dependence and withdrawal. Drug Alcohol Depend. 2022 07 01; 236:109468.
-
Messias E, Salas J, Scherrer JF. Patient characteristics prior to suicide attempts among Hispanics compared to non-Hispanic whites in the United States. J Affect Disord. 2022 07 01; 308:130-133.
-
McCarty TR, Chouairi F, Hathorn KE, Chan WW, Thompson CC. Trends and Socioeconomic Health Outcomes of Cannabis Use Among Patients With Gastroparesis: A United States Nationwide Inpatient Sample Analysis. J Clin Gastroenterol. 2022 04 01; 56(4):324-330.
-
Skajaa N, Adelborg K, Horv?th-Puh? E, Rothman KJ, Henderson VW, Thygesen LC, S?rensen HT. Stroke and Risk of Mental Disorders Compared With Matched General Population and Myocardial Infarction Comparators. Stroke. 2022 07; 53(7):2287-2298.
-
Sahker E, Pro G, Sakata M, Poudyal H, Jordan A, Furukawa TA. Factors supporting substance use improvement for Black Americans: A population health observational study. Drug Alcohol Depend. 2022 05 01; 234:109405.
-
Han B, Blanco C, Einstein EB, Compton WM. Mental health conditions and receipt of mental health care by illicit lysergic acid diethylamide (LSD) use status among young adults in the United States. Addiction. 2022 06; 117(6):1794-1800.
-
Dwyer MJ, Burrows CA, Drossel C, Raiff BR, Kirby KC. Using the novel functional purchase task to examine prescription stimulant drug effect preferences in college students. Exp Clin Psychopharmacol. 2022 Dec; 30(6):774-786.
-
Cucciare MA, Mengeling MA, Han X, Kennedy K, Torner J, Sadler AG. Experiencing Sexual Assault and/or Stalking-Related Behavior is Associated with Binge Drinking and Substance Use Consequences in Deployed U.S. Servicewomen. Womens Health Issues. 2022 Jul-Aug; 32(4):402-410.
-
Steele RW, Moran JH, Patton AL, Kokes CP, James LP, Storm EA, Schexnayder SM. The Spice of Death: Sudden Cardiac Arrest After Novel Psychoactive Substance Exposure. Pediatr Emerg Care. 2022 Jan 01; 38(1):e63-e64.
-
Hiranita T, Obeng S, Sharma A, Wilkerson JL, McCurdy CR, McMahon LR. In vitro and in vivo pharmacology of kratom. Adv Pharmacol. 2022; 93:35-76.
-
Hayes CJ, Krebs EE, Li C, Brown J, Hudson T, Martin BC. Association between discontinuing chronic opioid therapy and newly diagnosed substance use disorders, accidents, self-inflicted injuries and drug overdoses within the prescribers' health care system: a retrospective cohort study. Addiction. 2022 04; 117(4):946-968.
-
DeYoung OA, Boehmer K, Hung D, McAdam-Marx C. A historical cohort study of glycemic control in patients with concurrent type 2 diabetes and substance use disorder treated in a primary care setting. Fam Pract. 2021 09 25; 38(5):562-568.
-
Ikram H, Tasneem S, Perveen S, Zakir R, Jabeen Haleem D. Neurochemical and behavioral effects of fluoxetine on midazolam induce dependence in an animal model of addiction. Pak J Pharm Sci. 2021 Sep; 34(5):1749-1757.
-
Timko C, Rossi FS, Grant KM, Lor MC, Cucciare MA. Concerned others' help utilization and patients' alcohol treatment outcomes. Drug Alcohol Depend. 2021 11 01; 228:108983.
-
Jones DM, Masyn KE, Spears CA. Discrimination, psychological functioning, and substance use among U.S. young adults aged 18-28, 2017. Exp Clin Psychopharmacol. 2022 Dec; 30(6):884-896.
-
Sibley MH, Arnold LE, Swanson JM, Hechtman LT, Kennedy TM, Owens E, Molina BSG, Jensen PS, Hinshaw SP, Roy A, Chronis-Tuscano A, Newcorn JH, Rohde LA. Variable Patterns of Remission From ADHD in the Multimodal Treatment Study of ADHD. Am J Psychiatry. 2022 Feb; 179(2):142-151.
-
Glass JE, Matson TE, Lim C, Hartzler AL, Kimbel K, Lee AK, Beatty T, Parrish R, Caldeiro RM, Garza McWethy A, Curran GM, Bradley KA. Approaches for Implementing App-Based Digital Treatments for Drug Use Disorders Into Primary Care: A Qualitative, User-Centered Design Study of Patient Perspectives. J Med Internet Res. 2021 07 06; 23(7):e25866.
-
Timko C, Cucciare MA, Grant KM, Young LB, Rossi FS, Lor MC, Woodhead E. Patients With Alcohol Use Disorders and Their Concerned Others: Concordance of Lived Experience as a Moderator of Treatment Outcomes. J Stud Alcohol Drugs. 2021 05; 82(3):395-400.
-
Hammond AS, Sweeney MM, Chikosi TU, Stitzer ML. Digital delivery of a contingency management intervention for substance use disorder: A feasibility study with DynamiCare Health. J Subst Abuse Treat. 2021 07; 126:108425.
-
Ford J, Bushnell G, Griffith AM, Joodi G, Ashoka A, Patel N, Husain M, Pursell IW, Sears SF, Mounsey JP, Simpson RJ. Mental Disorders, Substance Use Disorders, and Psychotropic Medication Use Among Sudden-Death Victims. Psychiatr Serv. 2021 04 01; 72(4):378-383.
-
Traynor SM, Metsch LR, Gooden L, Stitzer M, Matheson T, Tross S, Carrico AW, Jain MK, Del Rio C, Feaster DJ. Self-efficacy as a mediator of patient navigation interventions to engage persons living with HIV and substance use. Drug Alcohol Depend. 2021 04 01; 221:108567.
-
Gorvine MM, Haynes TF, Marshall SA, Clark CJ, Lovelady NN, Zaller ND. An Exploratory Study of the Acceptability and Feasibility of Yoga Among Women in Substance Use Disorder Recovery. J Altern Complement Med. 2021 Mar; 27(3):273-281.
-
Zielinski MJ, Hinton KE, Bull CE. COVID-19 highlights the pitfalls of reliance on the carceral system as a response to addiction. J Subst Abuse Treat. 2021 03; 122:108190.
-
Acheson A. Behavioral processes and risk for problem substance use in adolescents. Pharmacol Biochem Behav. 2020 11; 198:173021.
-
Hammond AS, Antoine DG, Stitzer ML, Strain EC. A Randomized and Controlled Acceptability Trial of an Internet-based Therapy among Inpatients with Co-occurring Substance Use and Other Psychiatric Disorders. J Dual Diagn. 2020 10; 16(4):447-454.
-
McClenahan SJ, Gunnell MG, Owens SM, Fantegrossi WE. Active vaccination reduces reinforcing effects of MDPV in male Sprague-Dawley rats trained to self-administer cocaine. Psychopharmacology (Berl). 2020 Sep; 237(9):2613-2620.
-
Worley LLM, Wise-Ehlers A. Telepsychiatry in Obstetrics. Obstet Gynecol Clin North Am. 2020 Jun; 47(2):333-340.
-
McBain SA, Woodward E, Palmer BE, Landes SJ, Wilson MP. Patients accept screening for mental health and substance use disorders while ED clinicians support only if able to refer. Am J Emerg Med. 2020 12; 38(12):2727-2729.
-
Timko C, Grant KM, Mohankumar R, Cucciare MA. Functioning of adults in alcohol use disorder treatment: Role of concerned others. J Subst Abuse Treat. 2020 06; 113:108003.
-
Marsch LA, Campbell A, Campbell C, Chen CH, Ertin E, Ghitza U, Lambert-Harris C, Hassanpour S, Holtyn AF, Hser YI, Jacobs P, Klausner JD, Lemley S, Kotz D, Meier A, McLeman B, McNeely J, Mishra V, Mooney L, Nunes E, Stafylis C, Stanger C, Saunders E, Subramaniam G, Young S. The application of digital health to the assessment and treatment of substance use disorders: The past, current, and future role of the National Drug Abuse Treatment Clinical Trials Network. J Subst Abuse Treat. 2020 03; 112S:4-11.
-
Geoffroy PA, Tebeka S, Blanco C, Dubertret C, Le Strat Y. Shorter and longer durations of sleep are associated with an increased twelve-month prevalence of psychiatric and substance use disorders: Findings from a nationally representative survey of US adults (NESARC-III). J Psychiatr Res. 2020 05; 124:34-41.
-
Redmond N, Aminawung JA, Morse DS, Zaller N, Shavit S, Wang EA. Perceived Discrimination Based on Criminal Record in Healthcare Settings and Self-Reported Health Status among Formerly Incarcerated Individuals. J Urban Health. 2020 02; 97(1):105-111.
-
Hayes CJ, Krebs EE, Hudson T, Brown J, Li C, Martin BC. Impact of opioid dose escalation on the development of substance use disorders, accidents, self-inflicted injuries, opioid overdoses and alcohol and non-opioid drug-related overdoses: a retrospective cohort study. Addiction. 2020 06; 115(6):1098-1112.
-
Salgado Garc?a F, Bursac Z, Derefinko KJ. Cumulative Risk of Substance Use in Community College Students. Am J Addict. 2020 03; 29(2):97-104.
-
Camplain R, Camplain C, Trotter RT, Pro G, Sabo S, Eaves E, Peoples M, Baldwin JA. Racial/Ethnic Differences in Drug- and Alcohol-Related Arrest Outcomes in a Southwest County From 2009 to 2018. Am J Public Health. 2020 01; 110(S1):S85-S92.
-
Stanger C, Budney AJ. Contingency Management: Using Incentives to Improve Outcomes for Adolescent Substance Use Disorders. Pediatr Clin North Am. 2019 12; 66(6):1183-1192.
-
Lappan SN, Brown AW, Hendricks PS. Dropout rates of in-person psychosocial?substance use disorder treatments: a systematic review and meta-analysis. Addiction. 2020 02; 115(2):201-217.
-
Ecker AH, Lang B, Hogan J, Cucciare MA, Lindsay J. Cannabis use disorder among veterans: Comorbidity and mental health treatment utilization. J Subst Abuse Treat. 2020 02; 109:46-49.
-
McClenahan SJ, Kormos CM, Gunnell M, Hambuchen MD, Lamb P, Carroll FI, Lewin AH, Peterson EC, Owens SM. Design, synthesis and biological evaluation of a bi-specific vaccine against a-pyrrolidinovalerophenone (a-PVP) and 3,4-methylenedioxypyrovalerone (MDPV) in rats. Vaccine. 2020 01 10; 38(2):336-344.
-
Kroska EB, Meller EW, Doyle R, Coker JL, Knight BT, Ray-Griffith SL, Nembhard WN, Stowe ZN. Drug screening during pregnancy: Urine dip cups measure up. Drug Alcohol Depend. 2019 11 01; 204:107461.
-
Stitzer ML, Gukasyan N, Matheson T, Sorensen JL, Feaster DJ, Duan R, Gooden L, Del Rio C, Metsch LR. Enhancing patient navigation with contingent financial incentives for substance use abatement in persons with HIV and substance use. Psychol Addict Behav. 2020 Feb; 34(1):23-30.
-
Elton A, Stanger C, James GA, Ryan-Pettes S, Budney A, Kilts CD. Intertemporal decision-making-related brain states predict adolescent drug abuse intervention responses. Neuroimage Clin. 2019; 24:101968.
-
Hawkins MAW, Clawson AH, Smith CE, Stout ME, Keirns NG, Ruppe NM. Psychological distress and substance use among young adults with comorbid asthma and obesity. J Am Coll Health. 2020 Nov-Dec; 68(8):914-921.
-
Sahker E, Jones D, Lancianese DA, Pro G, Arndt S. Racial/Ethnic Differences in Alcohol and Drug Use Outcomes Following Screening, Brief Intervention, and Referral to Treatment (SBIRT) in Federally Qualified Health Centers. J Racial Ethn Health Disparities. 2019 12; 6(6):1192-1199.
-
Quisenberry AJ, Pittman J, Goodwin RD, Bickel WK, D'Urso G, Sheffer CE. Smoking relapse risk is increased among individuals in recovery. Drug Alcohol Depend. 2019 09 01; 202:93-103.
-
Ekhtiari H, Tavakoli H, Addolorato G, Baeken C, Bonci A, Campanella S, Castelo-Branco L, Challet-Bouju G, Clark VP, Claus E, Dannon PN, Del Felice A, den Uyl T, Diana M, di Giannantonio M, Fedota JR, Fitzgerald P, Gallimberti L, Grall-Bronnec M, Herremans SC, Herrmann MJ, Jamil A, Khedr E, Kouimtsidis C, Kozak K, Krupitsky E, Lamm C, Lechner WV, Madeo G, Malmir N, Martinotti G, McDonald WM, Montemitro C, Nakamura-Palacios EM, Nasehi M, No?l X, Nosratabadi M, Paulus M, Pettorruso M, Pradhan B, Praharaj SK, Rafferty H, Sahlem G, Salmeron BJ, Sauvaget A, Schluter RS, Sergiou C, Shahbabaie A, Sheffer C, Spagnolo PA, Steele VR, Yuan TF, van Dongen JDM, Van Waes V, Venkatasubramanian G, Verdejo-Garc?a A, Verveer I, Welsh JW, Wesley MJ, Witkiewitz K, Yavari F, Zarrindast MR, Zawertailo L, Zhang X, Cha YH, George TP, Frohlich F, Goudriaan AE, Fecteau S, Daughters SB, Stein EA, Fregni F, Nitsche MA, Zangen A, Bikson M, Hanlon CA. Transcranial electrical and magnetic stimulation (tES and TMS) for addiction medicine: A consensus paper on the present state of the science and the road ahead. Neurosci Biobehav Rev. 2019 09; 104:118-140.
-
Lovallo WR, Acheson A, Cohoon AJ, Sorocco KH, Vincent AS, Hodgkinson CA, Goldman D. Working memory reflects vulnerability to early life adversity as a risk factor for substance use disorder in the FKBP5 cortisol cochaperone polymorphism, rs9296158. PLoS One. 2019; 14(6):e0218212.
-
Dye DW, McGwin G, Atherton DS, McCleskey B, Davis GG. Correctly Identifying Deaths Due to Drug Toxicity Without a Forensic Autopsy. Am J Forensic Med Pathol. 2019 Jun; 40(2):99-101.
-
Lovallo WR, Cohoon AJ, Sorocco KH, Vincent AS, Acheson A, Hodgkinson CA, Goldman D. Early-Life Adversity and Blunted Stress Reactivity as Predictors of Alcohol and Drug use in Persons With COMT (rs4680) Val158Met Genotypes. Alcohol Clin Exp Res. 2019 07; 43(7):1519-1527.
-
Franco S, Olfson M, Wall MM, Wang S, Hoertel N, Blanco C. Shared and specific associations of substance use disorders on adverse outcomes: A national prospective study. Drug Alcohol Depend. 2019 08 01; 201:212-219.
-
Livingston R, Daily RS, Guerrero APS, Walkup JT, Novins DK. No Indians to Spare: Depression and Suicide in Indigenous American Children and Youth. Child Adolesc Psychiatr Clin N Am. 2019 07; 28(3):497-507.
-
Baker DE, Edmonds KA, Calvert ML, Sanders SM, Bridges AJ, Rhea MA, Kosloff S. Predicting attrition in long-term residential substance use disorder treatment: A modifiable risk factors perspective. Psychol Serv. 2020 Nov; 17(4):472-482.
-
Cucciare MA, Ounpraseuth ST, Curran GM, Booth BM. Predictors of mental health and substance use disorder treatment use over 3 years among rural adults using stimulants. Subst Abus. 2019; 40(3):363-370.
-
Wilson MP, Shenvi C, Rives L, Nordstrom K, Schneider S, Gerardi M. Opportunities for Research in Mental Health Emergencies: Executive Summary and Methodology. West J Emerg Med. 2019 Mar; 20(2):380-385.
-
Hawk KF, Glick RL, Jey AR, Gaylor S, Doucet J, Wilson MP, Rozel JS. Emergency Medicine Research Priorities for Early Intervention for Substance Use Disorders. West J Emerg Med. 2019 Mar; 20(2):386-392.
-
Fairman BJ, Furr-Holden CD, Johnson RM. When Marijuana Is Used before Cigarettes or Alcohol: Demographic Predictors and Associations with Heavy Use, Cannabis Use Disorder, and Other Drug-related Outcomes. Prev Sci. 2019 02; 20(2):225-233.
-
Petska HW, Porada K, Nugent M, Simpson P, Sheets LK. Occult drug exposure in young children evaluated for physical abuse: An opportunity for intervention. Child Abuse Negl. 2019 02; 88:412-419.
-
Acheson A, Vincent AS, Cohoon A, Lovallo WR. Early life adversity and increased delay discounting: Findings from the Family Health Patterns project. Exp Clin Psychopharmacol. 2019 Apr; 27(2):153-159.
-
van den Berg JJ, Zaller ND, Gillani FS, Dunsiger SI, Marshall BDL, Kahler CW, Operario D. Longitudinal HIV Transmission Risk Profiles Among Men Who Have Sex With Men Living With HIV in the SUN Study. Am J Mens Health. 2019 Jan-Feb; 13(1):1557988318818283.
-
Borders TF. Portraying a More Complete Picture of Illicit Drug Use Epidemiology and Policy for Rural America: A Competing Viewpoint to the CDC's MMWR Report. J Rural Health. 2018 12; 34(1):3-5.
-
Zaller N, Brinkley-Rubinstein L. Incarceration, drug use, and infectious diseases: a syndemic still not addressed. Lancet Infect Dis. 2018 12; 18(12):1301-1302.
-
Blanco C, Han B, Jones CM, Johnson K, Compton WM. Prevalence and Correlates of Benzodiazepine Use, Misuse, and Use Disorders Among Adults in the United States. J Clin Psychiatry. 2018 10 16; 79(6).
-
Martins BS, C?ceda R, Cisler JM, Kilts CD, James GA. The neural representation of the association between comorbid drug use disorders and childhood maltreatment. Drug Alcohol Depend. 2018 11 01; 192:215-222.
-
Sadeh N, Spielberg JM, Logue MW, Hayes JP, Wolf EJ, McGlinchey RE, Milberg WP, Schichman SA, Stone A, Miller MW. Linking genes, circuits, and behavior: network connectivity as a novel endophenotype of externalizing. Psychol Med. 2019 08; 49(11):1905-1913.
-
Gannon BM, Baumann MH, Walther D, Jimenez-Morigosa C, Sulima A, Rice KC, Collins GT. The abuse-related effects of pyrrolidine-containing cathinones are related to their potency and selectivity to inhibit the dopamine transporter. Neuropsychopharmacology. 2018 11; 43(12):2399-2407.
-
Timko C, Han X, Woodhead E, Shelley A, Cucciare MA. Polysubstance Use by Stimulant Users: Health Outcomes Over Three Years. J Stud Alcohol Drugs. 2018 09; 79(5):799-807.
-
Mitchell SG, Monico LB, Stitzer M, Matheson T, Sorensen JL, Feaster DJ, Schwartz RP, Metsch L. How patient navigators view the use of financial incentives to influence study involvement, substance use, and HIV treatment. J Subst Abuse Treat. 2018 11; 94:18-23.
-
Stitzer ML, Hammond AS, Matheson T, Sorensen JL, Feaster DJ, Duan R, Gooden L, Del Rio C, Metsch LR. Enhancing Patient Navigation with Contingent Incentives to Improve Healthcare Behaviors and Viral Load Suppression of Persons with HIV and Substance Use. AIDS Patient Care STDS. 2018 07; 32(7):288-296.
-
Derefinko KJ, Hallsell TA, Isaacs MB, Salgado Garcia FI, Colvin LW, Bursac Z, McDevitt-Murphy ME, Murphy JG, Little MA, Talcott GW, Klesges RC. Substance Use and Psychological Distress Before and After the Military to Civilian Transition. Mil Med. 2018 05 01; 183(5-6):e258-e265.
-
Compton WM, Han B, Blanco C, Johnson K, Jones CM. Prevalence and Correlates of Prescription Stimulant Use, Misuse, Use Disorders, and Motivations for Misuse Among Adults in the United States. Am J Psychiatry. 2018 08 01; 175(8):741-755.
-
Wong JJ, Cucciare MA, Booth BM, Timko C. Predicting Substance Use Patterns Among Rural Adults: The Roles of Mothers, Fathers, and Parenthood. Fam Process. 2019 06; 58(2):431-445.
-
Jensen PS, Weisner T, Hinshaw SP. Introduction: Just Say No? New Insights About Change Versus Constancy in Substance Use Behavioral Decisions in Youth With and Without ADHD. J Atten Disord. 2018 07; 22(9_suppl):3S-9S.
-
Patton AL, Seely KA, Yarbrough AL, Fantegrossi W, James LP, McCain KR, Fujiwara R, Prather PL, Moran JH, Radominska-Pandya A. Altered metabolism of synthetic cannabinoid JWH-018 by human cytochrome P450 2C9 and variants. Biochem Biophys Res Commun. 2018 04 06; 498(3):597-602.
-
Kangiser MM, Dwoskin LP, Zheng G, Crooks PA, Stairs DJ. Varenicline and GZ-793A differentially decrease methamphetamine self-administration under a multiple schedule of reinforcement in rats. Behav Pharmacol. 2018 02; 29(1):87-97.
-
Cucciare MA, Kennedy KM, Han X, Timko C, Zaller N, Booth BM. Utilization of outpatient medical care and substance use among rural stimulant users: Do the number of visits matter? J Subst Abuse Treat. 2018 03; 86:78-85.
-
George N, Harrell SM, Rhodes KD, Duarte-Rojo A. Recreational Drug and Psychosocial Profile in Chronic Hepatitis C Patients Seeking Antiviral Therapy. Ann Hepatol. 2018 January-February; 17(1):76-84.
-
Han B, Jones CM, Blanco C, Compton WM. National Trends in and Correlates of Nonmedical Use of Prescription Stimulants, Nonmedical Use Frequency, and Use Disorders. J Clin Psychiatry. 2017 Nov/Dec; 78(9):e1250-e1258.
-
Swanson JM, Wigal T, Jensen PS, Mitchell JT, Weisner TS, Murray D, Arnold LE, Hechtman L, Molina BSG, Owens EB, Hinshaw SP, Belendiuk K, Howard A, Wigal SB, Sorensen P, Stehli A. The Qualitative Interview Study of Persistent and Nonpersistent Substance Use in the MTA: Sample Characteristics, Frequent Use, and Reasons for Use. J Atten Disord. 2018 07; 22(9_suppl):21S-37S.
-
Acheson A, Vincent AS, Cohoon AJ, Lovallo WR. Defining the phenotype of young adults with family histories of alcohol and other substance use disorders: Studies from the family health patterns project. Addict Behav. 2018 Feb; 77:247-254.
-
Han B, Compton WM, Blanco C, Colpe LJ. Prevalence, Treatment, And Unmet Treatment Needs Of US Adults With Mental Health And Substance Use Disorders. Health Aff (Millwood). 2017 10 01; 36(10):1739-1747.
-
Woodward EN, Banks RJ, Marks AK, Pantalone DW. Identifying Resilience Resources for HIV Prevention Among Sexual Minority Men: A Systematic Review. AIDS Behav. 2017 Oct; 21(10):2860-2873.
-
Olfson M, Wall MM, Liu SM, Blanco C. Cannabis Use and Risk of Prescription Opioid Use Disorder in the United States. Am J Psychiatry. 2018 01 01; 175(1):47-53.
-
Light KE, Goodner K, Seaton VA, Boyle B, Hopkins R. State programs assisting pharmacy professionals with substance use disorders. J Am Pharm Assoc (2003). 2017 Nov - Dec; 57(6):704-710.
-
Urbano FJ, Bisagno V, Garcia-Rill E. Arousal and drug abuse. Behav Brain Res. 2017 08 30; 333:276-281.
-
Han B, Compton WM, Blanco C, DuPont RL. National Trends in Substance Use and Use Disorders Among Youth. J Am Acad Child Adolesc Psychiatry. 2017 Sep; 56(9):747-754.e3.
-
Hepner KA, Paddock SM, Watkins KE, Ounpraseuth ST, Schrader AM, Hudson TJ. Association Between Quality Measures and Perceptions of Care Among Patients With Substance Use Disorders. Psychiatr Serv. 2017 Nov 01; 68(11):1150-1156.
-
Stitzer M, Matheson T, Cunningham C, Sorensen JL, Feaster DJ, Gooden L, Hammond AS, Fitzsimons H, Metsch LR. Enhancing patient navigation to improve intervention session attendance and viral load suppression of persons with HIV and substance use: a secondary post hoc analysis of the Project HOPE study. Addict Sci Clin Pract. 2017 06 27; 12(1):16.
-
Chou SP, Saha TD, Zhang H, Ruan WJ, Huang B, Grant BF, Blanco C, Compton W. Prevalence, correlates, comorbidity and treatment of electronic nicotine delivery system use in the United States. Drug Alcohol Depend. 2017 09 01; 178:296-301.
-
Zaller N, Yang C, Operario D, Latkin C, McKirnan D, O'Donnell L, Fernandez M, Seal D, Koblin B, Flores S, Spikes P. Alcohol and cocaine use among Latino and African American MSM in 6 US cities. J Subst Abuse Treat. 2017 09; 80:26-32.
-
Weisner TS, Murray DW, Jensen PS, Mitchell JT, Swanson JM, Hinshaw SP, Wells K, Hechtman L, Molina BSG, Arnold LE, Sorensen P, Stehli A. Follow-Up of Young Adults With ADHD in the MTA: Design and Methods for Qualitative Interviews. J Atten Disord. 2018 07; 22(9_suppl):10S-20S.
-
Timko C, Hoggatt KJ, Wu FM, Tjemsland A, Cucciare M, Rubin A, Simpson TL. Substance Use Disorder Treatment Services for Women in the Veterans Health Administration. Womens Health Issues. 2017 Nov - Dec; 27(6):639-645.
-
Hagedorn HJ, Noorbaloochi S, Bangerter A, Stitzer ML, Kivlahan D. Health care cost trajectories in the year prior to and following intake into Veterans Health Administration outpatient substance use disorders treatment. J Subst Abuse Treat. 2017 08; 79:46-52.
-
Vanderzee KL, John SG, Edge N, Pemberton JR, Kramer TL. A PRELIMINARY EVALUATION OF THE MANAGING YOUTH TRAUMA EFFECTIVELY PROGRAM FOR SUBSTANCE-ABUSING WOMEN AND THEIR CHILDREN. Infant Ment Health J. 2017 05; 38(3):422-433.
-
Paddock SM, Hepner KA, Hudson T, Ounpraseuth S, Schrader AM, Sullivan G, Watkins KE. Association Between Process-Based Quality Indicators and Mortality for Patients With Substance Use Disorders. J Stud Alcohol Drugs. 2017 05; 78(4):588-596.
-
Coker JL, Mease A, Lowery C. Pregnant Women, Babies and Substance Use: Prevention of Neonatal Abstinence Syndrome. J Ark Med Soc. 2017 May; 113(11):264-265.
-
Jensen PS, Yuki K, Murray D, Mitchell JT, Weisner T, Hinshaw S, Molina B, Swanson J, Arnold LE, Hechtman L, Wells K. Turning Points in the Lives of Youth of With/Without ADHD: Are They Linked to Changes in Substance Use? J Atten Disord. 2018 07; 22(9_suppl):38S-48S.
-
Stanger C, Scherer EA, Babbin SF, Ryan SR, Budney AJ. Abstinence based incentives plus parent training for adolescent alcohol and other substance misuse. Psychol Addict Behav. 2017 06; 31(4):385-392.
-
Bondurant K. Preventing Substance Abuse With Data-Driven Coalitions. J Ark Med Soc. 2017 Apr; 113(10):240-241.
-
Brinkley-Rubinstein L, Cloud DH, Davis C, Zaller N, Delany-Brumsey A, Pope L, Martino S, Bouvier B, Rich J. Addressing excess risk of overdose among recently incarcerated people in the USA: harm reduction interventions in correctional settings. Int J Prison Health. 2017 03 13; 13(1):25-31.
-
Blow FC, Walton MA, Bohnert ASB, Ignacio RV, Chermack S, Cunningham RM, Booth BM, Ilgen M, Barry KL. A randomized controlled trial of brief interventions to reduce drug use among adults in a low-income urban emergency department: the HealthiER You study. Addiction. 2017 Aug; 112(8):1395-1405.
-
Fairman BJ, Hwang S, Alexandre PK, Gallo JJ, Eaton WW. Costs of substance use disorders from claims data for Medicare recipients from a population-based sample. J Subst Abuse Treat. 2017 06; 77:174-177.
-
Ford BM, Tai S, Fantegrossi WE, Prather PL. Synthetic Pot: Not Your Grandfather's Marijuana. Trends Pharmacol Sci. 2017 03; 38(3):257-276.
-
Mitchell JT, Weisner TS, Jensen PS, Murray DW, Molina BSG, Arnold LE, Hechtman L, Swanson JM, Hinshaw SP, Victor EC, Kollins SH, Wells KC, Belendiuk KA, Blonde A, Nguyen C, Ambriz L, Nguyen JL. How Substance Users With ADHD Perceive the Relationship Between Substance Use and Emotional Functioning. J Atten Disord. 2018 07; 22(9_suppl):49S-60S.
-
Acheson A, Wijtenburg SA, Rowland LM, Winkler A, Mathias CW, Hong LE, Jahanshad N, Patel B, Thompson PM, McGuire SA, Sherman PM, Kochunov P, Dougherty DM. Reproducibility of tract-based white matter microstructural measures using the ENIGMA-DTI protocol. Brain Behav. 2017 02; 7(2):e00615.
-
Charles NE, Mathias CW, Acheson A, Dougherty DM. Preadolescent sensation seeking and early adolescent stress relate to at-risk adolescents' substance use by age 15. Addict Behav. 2017 06; 69:1-7.
-
Katz JL, Hiranita T, Hong WC, Job MO, McCurdy CR. A Role for Sigma Receptors in Stimulant Self-Administration and Addiction. Handb Exp Pharmacol. 2017; 244:177-218.
-
House SJ, Coker JL, Stowe ZN. Perinatal Substance Abuse: At the Clinical Crossroads of Policy and Practice. Am J Psychiatry. 2016 11 01; 173(11):1077-1080.
-
Olfson M, Wall M, Wang S, Crystal S, Liu SM, Gerhard T, Blanco C. Short-term Suicide Risk After Psychiatric Hospital Discharge. JAMA Psychiatry. 2016 Nov 01; 73(11):1119-1126.
-
Acheson A, Lake SL, Bray BC, Liang Y, Mathias CW, Ryan SR, Charles NE, Dougherty DM. Early Adolescent Trajectories of Impulsiveness and Sensation Seeking in Children of Fathers with Histories of Alcohol and Other Substance Use Disorders. Alcohol Clin Exp Res. 2016 12; 40(12):2622-2630.
-
Stanger C, Lansing AH, Budney AJ. Advances in Research on Contingency Management for Adolescent Substance Use. Child Adolesc Psychiatr Clin N Am. 2016 10; 25(4):645-59.
-
L?vesque A, Campbell AN, Pavlicova M, Hu MC, Walker R, McClure EA, Ghitza UE, Bailey G, Stitzer M, Nunes EV. Coping strategies as a mediator of internet-delivered psychosocial treatment: Secondary analysis from a NIDA CTN multisite effectiveness trial. Addict Behav. 2017 02; 65:74-80.
-
Rash CJ, Stitzer M, Weinstock J. Contingency Management: New Directions and Remaining Challenges for An Evidence-Based Intervention. J Subst Abuse Treat. 2017 01; 72:10-18.
-
Hechtman L, Swanson JM, Sibley MH, Stehli A, Owens EB, Mitchell JT, Arnold LE, Molina BS, Hinshaw SP, Jensen PS, Abikoff HB, Perez Algorta G, Howard AL, Hoza B, Etcovitch J, Houssais S, Lakes KD, Nichols JQ. Functional Adult Outcomes 16 Years After Childhood Diagnosis of Attention-Deficit/Hyperactivity Disorder: MTA Results. J Am Acad Child Adolesc Psychiatry. 2016 11; 55(11):945-952.e2.
-
Compton WM, Han B, Jones CM, Blanco C, Hughes A. Marijuana use and use disorders in adults in the USA, 2002-14: analysis of annual cross-sectional surveys. Lancet Psychiatry. 2016 Oct; 3(10):954-964.
-
Stitzer M, Calsyn D, Matheson T, Sorensen J, Gooden L, Metsch L. Development of a Multi-Target Contingency Management Intervention for HIV Positive Substance Users. J Subst Abuse Treat. 2017 01; 72:66-71.
-
Zaller N, Cheney AM, Curran GM, Booth BM, Borders TF. The Criminal Justice Experience of African American Cocaine Users in Arkansas. Subst Use Misuse. 2016 10 14; 51(12):1566-1576.
-
Timko C, Schultz NR, Britt J, Cucciare MA. Transitioning From Detoxification to Substance Use Disorder Treatment: Facilitators and Barriers. J Subst Abuse Treat. 2016 11; 70:64-72.
-
Metsch LR, Feaster DJ, Gooden L, Matheson T, Stitzer M, Das M, Jain MK, Rodriguez AE, Armstrong WS, Lucas GM, Nijhawan AE, Drainoni ML, Herrera P, Vergara-Rodriguez P, Jacobson JM, Mugavero MJ, Sullivan M, Daar ES, McMahon DK, Ferris DC, Lindblad R, VanVeldhuisen P, Oden N, Castell?n PC, Tross S, Haynes LF, Douaihy A, Sorensen JL, Metzger DS, Mandler RN, Colfax GN, del Rio C. Effect of Patient Navigation With or Without Financial Incentives on Viral Suppression Among Hospitalized Patients With HIV Infection and Substance Use: A Randomized Clinical Trial. JAMA. 2016 Jul 12; 316(2):156-70.
-
Lee JH, Gamarel KE, Bryant KJ, Zaller ND, Operario D. Discrimination, Mental Health, and Substance Use Disorders Among Sexual Minority Populations. LGBT Health. 2016 08; 3(4):258-65.
-
Herrmann ES, Matusiewicz AK, Stitzer ML, Higgins ST, Sigmon SC, Heil SH. Contingency Management Interventions for HIV, Tuberculosis, and Hepatitis Control Among Individuals With Substance Use Disorders: A Systematized Review. J Subst Abuse Treat. 2017 01; 72:117-125.
-
Watkins KE, Paddock SM, Hudson TJ, Ounpraseuth S, Schrader AM, Hepner KA, Sullivan G. Association Between Quality Measures and Mortality in Individuals With Co-Occurring Mental Health and Substance Use Disorders. J Subst Abuse Treat. 2016 10; 69:1-8.
-
Schultz NR, Martinez R, Cucciare MA, Timko C. Patient, Program, and System Barriers and Facilitators to Detoxification Services in the U.S. Veterans Health Administration: A Qualitative Study of Provider Perspectives. Subst Use Misuse. 2016 08 23; 51(10):1330-41.
-
Friedman CK, Ryan SR, Charles NE, Mathias CW, Acheson A, Dougherty DM. Child Problems as a Moderator of Relations Between Maternal Impulsivity and Family Environment in a High-Risk Sample. Subst Use Misuse. 2016 08 23; 51(10):1264-73.
-
Olfson M, Mojtabai R, Merikangas KR, Compton WM, Wang S, Grant BF, Blanco C. Reexamining associations between mania, depression, anxiety and substance use disorders: results from a prospective national cohort. Mol Psychiatry. 2017 02; 22(2):235-241.
-
Timko C, Kong C, Vittorio L, Cucciare MA. Screening and brief intervention for unhealthy substance use in patients with chronic medical conditions: a systematic review. J Clin Nurs. 2016 Nov; 25(21-22):3131-3143.
-
Charles NE, Ryan SR, Bray BC, Mathias CW, Acheson A, Dougherty DM. Altered developmental trajectories for impulsivity and sensation seeking among adolescent substance users. Addict Behav. 2016 09; 60:235-41.
-
Cheney AM, Booth BM, Borders TF, Curran GM. The Role of Social Capital in African Americans' Attempts to Reduce and Quit Cocaine Use. Subst Use Misuse. 2016 05 11; 51(6):777-87.
-
Blanco C, Hasin DS, Wall MM, Fl?rez-Salamanca L, Hoertel N, Wang S, Kerridge BT, Olfson M. Cannabis Use and Risk of Psychiatric Disorders: Prospective Evidence From a US National Longitudinal Study. JAMA Psychiatry. 2016 Apr; 73(4):388-95.
-
Katz JL, Hong WC, Hiranita T, Su TP. A role for sigma receptors in stimulant self-administration and addiction. Behav Pharmacol. 2016 Apr; 27(2-3 Spec Issue):100-15.
-
Bondurant K. Preventing Substance Abuse With Data-Driven Coalitions. J Ark Med Soc. 2016 Apr; 112(12):228-9.
-
Garneau-Fournier J, McBain S, Torres T, Turchik J. Sexual Dysfunction Problems in Female College Students: Sexual Victimization, Substance Use, and Personality Factors. J Sex Marital Ther. 2017 Jan 02; 43(1):24-39.
-
McLafferty LP, Becker M, Dresner N, Meltzer-Brody S, Gopalan P, Glance J, Victor GS, Mittal L, Marshalek P, Lander L, Worley LL. Guidelines for the Management of Pregnant Women With Substance Use Disorders. Psychosomatics. 2016 Mar-Apr; 57(2):115-30.
-
Cunningham C, Stitzer M, Campbell AN, Pavlicova M, Hu MC, Nunes EV. Contingency Management Abstinence Incentives: Cost and Implications for Treatment Tailoring. J Subst Abuse Treat. 2017 01; 72:134-139.
-
Johnson RM, Fairman B, Gilreath T, Xuan Z, Rothman EF, Parnham T, Furr-Holden CD. Past 15-year trends in adolescent marijuana use: Differences by race/ethnicity and sex. Drug Alcohol Depend. 2015 Oct 01; 155:8-15.
-
Budney AJ, Lee DC, Juliano LM. Evaluating the Validity of Caffeine Use Disorder. Curr Psychiatry Rep. 2015 Sep; 17(9):74.
-
Cucciare MA, Timko C. Bridging the gap between medical settings and specialty addiction treatment. Addiction. 2015 Sep; 110(9):1417-9.
-
Golden LE, Sassoon P, C?ceda R. A case report of late onset psychosis with dementia and aspirin and caffeine addiction. Schizophr Res. 2015 Oct; 168(1-2):591-2.
-
Dougherty DM, Lake SL, Mathias CW, Ryan SR, Bray BC, Charles NE, Acheson A. Behavioral Impulsivity and Risk-Taking Trajectories Across Early Adolescence in Youths With and Without Family Histories of Alcohol and Other Drug Use Disorders. Alcohol Clin Exp Res. 2015 Aug; 39(8):1501-9.
-
Knight DA, Jarrett D. Preventive Health Care for Men Who Have Sex with Men. Am Fam Physician. 2015 Jun 15; 91(12):844-51.
-
Booth BM, Wright PB, Ounpraseuth ST, Stewart KE. Trajectory of substance use after an HIV risk reduction intervention. Am J Drug Alcohol Abuse. 2015; 41(4):345-52.
-
Curran GM, Woo SM, Hepner KA, Lai WP, Kramer TL, Drummond KL, Weingardt K. Training Substance Use Disorder Counselors in Cognitive Behavioral Therapy for Depression: Development and Initial Exploration of an Online Training Program. J Subst Abuse Treat. 2015 Nov; 58:33-42.
-
Acheson A, Tagamets MA, Winkler A, Rowland LM, Mathias CW, Wright SN, Hong LE, Kochunov P, Dougherty DM. Striatal activity and reduced white matter increase frontal activity in youths with family histories of alcohol and other substance-use disorders performing a go/no-go task. Brain Behav. 2015 Jul; 5(7):e00352.
-
Cochran G, Gordon AJ, Field C, Bacci J, Dhital R, Ylioja T, Stitzer M, Kelly T, Tarter R. Developing a framework of care for opioid medication misuse in community pharmacy. Res Social Adm Pharm. 2016 Mar-Apr; 12(2):293-301.
-
Pyne JM. Expanding the Scope of Integrated Behavioral Health Care for Patients With Hepatitis C Virus. Clin Gastroenterol Hepatol. 2015 Nov; 13(11):2015-6.
-
Budney AJ, Stanger C, Tilford JM, Scherer EB, Brown PC, Li Z, Li Z, Walker DD. Computer-assisted behavioral therapy and contingency management for cannabis use disorder. Psychol Addict Behav. 2015 Sep; 29(3):501-11.
-
Peters EN, Nordeck C, Zanetti G, O'Grady KE, Serpelloni G, Rimondo C, Blanco C, Welsh C, Schwartz RP. Relationship of gambling with tobacco, alcohol, and illicit drug use among adolescents in the USA: Review of the literature 2000-2014. Am J Addict. 2015 Apr; 24(3):206-216.
-
Mereish EH, Lee JH, Gamarel KE, Zaller ND, Operario D. Sexual orientation disparities in psychiatric and drug use disorders among a nationally representative sample of women with alcohol use disorders. Addict Behav. 2015 Aug; 47:80-5.
-
Lee JH, Gamarel KE, Kahler CW, Marshall BD, van den Berg JJ, Bryant K, Zaller ND, Operario D. Co-occurring psychiatric and drug use disorders among sexual minority men with lifetime alcohol use disorders. Drug Alcohol Depend. 2015 Jun 01; 151:167-72.
-
Cucciare MA, Cheung RC, Rongey C. Treating substance use disorders in patients with hepatitis C. Addiction. 2015 Jul; 110(7):1057-9.
-
Charles NE, Mathias CW, Acheson A, Bray BC, Ryan SR, Lake SL, Liang Y, Dougherty DM. Increased Pre- and Early-Adolescent Stress in Youth with a Family History of Substance Use Disorder and Early Substance Use Initiation. J Youth Adolesc. 2015 Oct; 44(10):1954-67.
-
Blanco C, Garc?a-Anaya M, Wall M, de Los Cobos JC, Swierad E, Wang S, Petry NM. Should pathological gambling and obesity be considered addictive disorders? A factor analytic study in a nationally representative sample. Drug Alcohol Depend. 2015 May 01; 150:129-34.
-
Adams JA, Kellogg ND, Farst KJ, Harper NS, Palusci VJ, Frasier LD, Levitt CJ, Shapiro RA, Moles RL, Starling SP. Updated Guidelines for the Medical Assessment and Care of Children Who May Have Been Sexually Abused. J Pediatr Adolesc Gynecol. 2016 Apr; 29(2):81-87.
-
Blanco C, Iza M, Rodr?guez-Fern?ndez JM, Baca-Garc?a E, Wang S, Olfson M. Probability and predictors of treatment-seeking for substance use disorders in the U.S. Drug Alcohol Depend. 2015 Apr 01; 149:136-44.
-
Cochran G, Stitzer M, Campbell AN, Hu MC, Vandrey R, Nunes EV. Web-based treatment for substance use disorders: differential effects by primary substance. Addict Behav. 2015 Jun; 45:191-4.
-
Marshall BD, Shoveller JA, Kahler CW, Koblin BA, Mayer KH, Mimiaga MJ, van den Berg JJ, Zaller ND, Operario D. Heavy drinking trajectories among men who have sex with men: a longitudinal, group-based analysis. Alcohol Clin Exp Res. 2015 Feb; 39(2):380-9.
-
Finley EP, Bollinger M, No?l PH, Amuan ME, Copeland LA, Pugh JA, Dassori A, Palmer R, Bryan C, Pugh MJ. A national cohort study of the association between the polytrauma clinical triad and suicide-related behavior among US Veterans who served in Iraq and Afghanistan. Am J Public Health. 2015 Feb; 105(2):380-7.
-
Hoggatt KJ, Jamison AL, Lehavot K, Cucciare MA, Timko C, Simpson TL. Alcohol and drug misuse, abuse, and dependence in women veterans. Epidemiol Rev. 2015; 37:23-37.
-
Zaller N, Topletz A, Frater S, Yates G, Lally M. Profiles of medicinal cannabis patients attending compassion centers in rhode island. J Psychoactive Drugs. 2015 Jan-Mar; 47(1):18-23.
-
Cunningham RM, Carter PM, Ranney M, Zimmerman MA, Blow FC, Booth BM, Goldstick J, Walton MA. Violent reinjury and mortality among youth seeking emergency department care for assault-related injury: a 2-year prospective cohort study. JAMA Pediatr. 2015 Jan; 169(1):63-70.
-
Engel A, C?ceda R. Can Decision Making Research Provide a Better Understanding of Chemical and Behavioral Addictions? Curr Drug Abuse Rev. 2015; 8(2):75-85.
-
McClure EA, Campbell AN, Pavlicova M, Hu M, Winhusen T, Vandrey RG, Ruglass LM, Covey LS, Stitzer ML, Kyle TL, Nunes EV. Cigarette Smoking During Substance Use Disorder Treatment: Secondary Outcomes from a National Drug Abuse Treatment Clinical Trials Network study. J Subst Abuse Treat. 2015 Jun; 53:39-46.
-
Stoddard SA, Epstein-Ngo Q, Walton MA, Zimmerman MA, Chermack ST, Blow FC, Booth BM, Cunningham RM. Substance use and violence among youth: a daily calendar analysis. Subst Use Misuse. 2015 Feb; 50(3):328-39.
-
Acheson A, Tagamets MA, Rowland LM, Mathias CW, Wright SN, Hong LE, Kochunov P, Dougherty DM. Increased forebrain activations in youths with family histories of alcohol and other substance use disorders performing a Go/NoGo task. Alcohol Clin Exp Res. 2014 Dec; 38(12):2944-51.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|